Home Search

viaskin - search results

If you're not happy with the results, please do another search
Viaskin Patch

Viaskin Milk Results Shows Potential for Treatment of Milk Allergy in Children

0
95.5% of the participants completed treatment, with most adverse effects being mild or moderate reactions at the application site.
Viaskin Peanut

DBV Announces Promising 2-Year Results from Ongoing Viaskin “Peanut Patch” Toddler Study

81.3% of subjects who completed the oral food challenge reached an eliciting dose of ≥1,000 mg after 24 months of treatment.
Viaskin Peanut

DBV Outlines Path to Regulatory Approval of Viaskin Peanut Patch

0
Are Viaskin therapies finally on the horizon?
Viaskin Peanut

FDA Issues Partial Hold on DBV Viaskin Peanut Patch Trial

0
Another delay for the long-awaited therapy.
Viaskin Patch

DBV Begins Phase 3 Study of Redesigned Viaskin Peanut Patch in Children Ages 4-7

0
Viaskin is testing a new version of their patch designed to address the FDA's concerns.
Viaskin Patch

DBV Announces Positive Topline Results from Phase 3 Trial of Viaskin Peanut in Peanut-Allergic...

Viaskin Peanut demonstrated a statistically significant treatment effect with 67.0% of subjects meeting the treatment responder criteria after 12 months.
Viaskin Patch

Viaskin Peanut Patch Therapy Delayed Further as DBV Readies Another Phase 3 Trial

0
The patch therapy remains in regulatory limbo.
Viaskin-Patch

Safety of Viaskin Peanut Patch Therapy Improved Over 3-Year Study

0
Reactions decreased over study duration.
Viaskin Peanut

FDA Wants More Viaskin Peanut Data Resulting in Further Approval Delays

0
Delays mount pushing trials of modified patch.
Viaskin Patch

DBV Optimistic Viaskin Peanut “Patch” Therapy has Path to Approval After FDA Feedback

0
DBV, which also has Viaskin therapies for milk and egg allergies in their pipeline, is encouraged by FDA feedback after denial of their peanut therapy.